JP2020500870A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2020500870A5 JP2020500870A5 JP2019529218A JP2019529218A JP2020500870A5 JP 2020500870 A5 JP2020500870 A5 JP 2020500870A5 JP 2019529218 A JP2019529218 A JP 2019529218A JP 2019529218 A JP2019529218 A JP 2019529218A JP 2020500870 A5 JP2020500870 A5 JP 2020500870A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- dissolution test
- cancer
- acid
- composition according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR1020160161931A KR20180062063A (ko) | 2016-11-30 | 2016-11-30 | 서방형 항암용 약학 조성물 |
| KR10-2016-0161931 | 2016-11-30 | ||
| PCT/IB2017/054091 WO2018100442A1 (en) | 2016-11-30 | 2017-07-07 | Calcium lactate compositions and methods of use |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2020500870A JP2020500870A (ja) | 2020-01-16 |
| JP2020500870A5 true JP2020500870A5 (https=) | 2020-08-20 |
Family
ID=62242802
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019529218A Pending JP2020500870A (ja) | 2016-11-30 | 2017-07-07 | 乳酸カルシウム組成物および使用法 |
Country Status (12)
| Country | Link |
|---|---|
| US (3) | US11285121B2 (https=) |
| EP (1) | EP3547999A4 (https=) |
| JP (1) | JP2020500870A (https=) |
| KR (3) | KR20180062063A (https=) |
| CN (2) | CN117180249A (https=) |
| AR (1) | AR110302A1 (https=) |
| AU (2) | AU2017368901B2 (https=) |
| MX (1) | MX2019006291A (https=) |
| MY (1) | MY206468A (https=) |
| PH (1) | PH12019501199A1 (https=) |
| TW (2) | TWI827535B (https=) |
| WO (1) | WO2018100442A1 (https=) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA3087953C (en) | 2018-01-12 | 2025-11-25 | Metimedi Pharmaceuticals Co., Ltd. | METHODS OF TREATMENT FOR CHRONIC INFLAMMATORY DISEASES |
| US12097043B2 (en) | 2018-06-06 | 2024-09-24 | Masimo Corporation | Locating a locally stored medication |
| CN112512406A (zh) * | 2018-06-06 | 2021-03-16 | 梅西莫股份有限公司 | 阿片类药物过量监测 |
| KR101998246B1 (ko) * | 2018-08-22 | 2019-07-10 | 주식회사 메타파인즈 | 금속이온에 결합된 이온화합물을 포함하는 암 치료용 약학 조성물 |
| US11464410B2 (en) | 2018-10-12 | 2022-10-11 | Masimo Corporation | Medical systems and methods |
| US20220265586A1 (en) * | 2019-06-10 | 2022-08-25 | Ponce De Leon Health Designated Activity Company | Sustained-release compositions of alpha-ketoglutarate |
| EP4093507A4 (en) * | 2020-01-24 | 2024-02-28 | Barkey, Daniel, Q. | WEIGHT LOSS COMPOSITIONS AND METHODS |
| JP7737391B2 (ja) | 2020-03-20 | 2025-09-10 | マシモ・コーポレイション | 非侵襲的な体温測定のためのウェアラブルデバイス |
| US20230310327A1 (en) * | 2020-08-03 | 2023-10-05 | Natco Pharma Limited | Pharmaceutical compositions comprising ribociclib |
| KR102840190B1 (ko) * | 2022-04-19 | 2025-07-29 | (의) 삼성의료재단 | 생리활성물질 전달체 |
| WO2024242545A1 (ko) * | 2023-05-23 | 2024-11-28 | (주) 메티메디제약 | 칼슘 락테이트를 활성 성분으로 포함하는 암 백신 조성물 및 그 용도 |
| EP4502147A1 (en) | 2023-07-31 | 2025-02-05 | M2Rlab SL | Method for the polarization of cells to a new m2 phenotype and uses of said m2-polarized cells |
Family Cites Families (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3279997A (en) * | 1963-10-22 | 1966-10-18 | Herbert D Schneyer | Enteric coated calcium lactate tablets containing an antihistamine and thiamine chloride |
| JPS4837815B1 (https=) * | 1970-09-25 | 1973-11-14 | Yamanouchi Pharma Co Ltd | |
| EP0364696B1 (en) * | 1988-08-22 | 1993-03-17 | Takeda Chemical Industries, Ltd. | Alpha-glucosidase inhibitor as a calcium absorption promotor |
| US5980951A (en) * | 1996-04-10 | 1999-11-09 | Merck & Co., Inc. | Oral coated active drugs |
| DE10233229A1 (de) * | 2002-07-22 | 2004-02-12 | S.K. Enterprise Gmbh | Pharmazeutische Zusammensetzung zur Senkung des Triglyceridspiegels |
| CA2509620A1 (en) * | 2002-12-17 | 2004-07-01 | Wakunaga Pharmaceutical Co., Ltd. | Light-shielding agent and film-forming composition |
| ES2255429B1 (es) * | 2004-10-25 | 2007-08-16 | Italfarmaco, S.A. | Composiciones farmaceuticas bucodispersables. |
| US20060280795A1 (en) * | 2005-06-08 | 2006-12-14 | Dexcel Pharma Technologies, Ltd. | Specific time-delayed burst profile delivery system |
| CN1961957A (zh) * | 2005-11-09 | 2007-05-16 | 天津市礼人医药科技有限公司 | 一种抗衰老结肠吸收制剂 |
| UA95093C2 (uk) * | 2005-12-07 | 2011-07-11 | Нікомед Фарма Ас | Спосіб одержання кальцієвмісної сполуки |
| TW200808380A (en) | 2006-02-21 | 2008-02-16 | Shinetsu Chemical Co | Enteric-coated preparation for site-specific delivery of drug to site within the small intestine |
| JP2008044927A (ja) * | 2006-02-21 | 2008-02-28 | Shin Etsu Chem Co Ltd | 小腸内部位特異的薬物デリバリーのための腸溶性コーティング基剤で被覆した腸溶性製剤 |
| WO2008090569A1 (en) * | 2007-01-25 | 2008-07-31 | Panacea Biotec Ltd | Modified release pharmaceutical composition and a process of making the same |
| CN101139281A (zh) * | 2007-10-16 | 2008-03-12 | 陈杰 | 纳米乳酸钙及其制备方法 |
| CN101385696B (zh) * | 2008-07-29 | 2012-01-04 | 北京圣医耀科技发展有限责任公司 | 含依托泊苷的海藻酸钠微球血管栓塞剂及制备方法与用途 |
| CN102448439A (zh) * | 2009-03-26 | 2012-05-09 | 普马特里克斯公司 | 用于改变黏膜内衬的生物物理特性的柠檬酸钙及乳酸钙调配物 |
| US8247000B2 (en) * | 2009-04-10 | 2012-08-21 | Cypress Pharmaceutical, Inc. | Phosphate-binding magnesium salts and uses thereof |
| EP2599477A1 (en) | 2011-11-30 | 2013-06-05 | Lunamed AG | 4-Phenylbutyric acid sustained release formulation |
| CN102823872B (zh) * | 2012-08-22 | 2014-01-15 | 安徽泰格生物技术股份有限公司 | 包膜乳酸钙颗粒及其制备方法 |
| EP2968176B1 (en) * | 2013-03-15 | 2019-08-21 | Cerolife LLC | Orally administrable compositions comprising calcium |
| CN103316033B (zh) * | 2013-07-03 | 2015-07-15 | 康晓飞 | 一种凝胶剂及其用途 |
| US10386359B2 (en) * | 2014-05-23 | 2019-08-20 | Inserm (Institut National De La Sante Et De La Recherche Medicale) | Methods for determining whether a patient will achieve a response after radiation therapy |
| CN104523612A (zh) * | 2014-12-05 | 2015-04-22 | 海南卫康制药(潜山)有限公司 | 一种乳酸钙组合物咀嚼片及其制备方法 |
| KR101683635B1 (ko) | 2014-12-29 | 2016-12-09 | 가천대학교 산학협력단 | 락테이트 금속염을 포함하는 암 치료용 약학 조성물 |
| CN107898808B (zh) * | 2017-10-31 | 2021-04-27 | 华仁药业股份有限公司 | 小儿用静脉营养制剂 |
-
2016
- 2016-11-30 KR KR1020160161931A patent/KR20180062063A/ko active Pending
-
2017
- 2017-07-07 CN CN202311101709.6A patent/CN117180249A/zh active Pending
- 2017-07-07 US US16/464,924 patent/US11285121B2/en active Active
- 2017-07-07 WO PCT/IB2017/054091 patent/WO2018100442A1/en not_active Ceased
- 2017-07-07 MY MYPI2019003081A patent/MY206468A/en unknown
- 2017-07-07 AU AU2017368901A patent/AU2017368901B2/en active Active
- 2017-07-07 KR KR1020197017854A patent/KR102512475B1/ko active Active
- 2017-07-07 JP JP2019529218A patent/JP2020500870A/ja active Pending
- 2017-07-07 MX MX2019006291A patent/MX2019006291A/es unknown
- 2017-07-07 CN CN201780073923.1A patent/CN110087632B/zh active Active
- 2017-07-07 EP EP17876082.3A patent/EP3547999A4/en active Pending
- 2017-07-07 KR KR1020227045956A patent/KR20230004968A/ko not_active Withdrawn
- 2017-11-28 TW TW106141375A patent/TWI827535B/zh active
- 2017-11-28 TW TW112132795A patent/TWI841481B/zh active
- 2017-11-30 AR ARP170103364A patent/AR110302A1/es not_active Application Discontinuation
-
2019
- 2019-05-30 PH PH12019501199A patent/PH12019501199A1/en unknown
-
2022
- 2022-02-24 US US17/652,427 patent/US12059397B2/en active Active
-
2023
- 2023-09-14 AU AU2023229549A patent/AU2023229549A1/en not_active Abandoned
-
2024
- 2024-06-28 US US18/759,093 patent/US20240350439A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2020500870A5 (https=) | ||
| KR102512475B1 (ko) | 칼슘 락테이트 조성물 및 사용 방법 | |
| JP2010522742A (ja) | タクロリムスの修飾型剤形 | |
| TW201210593A (en) | Compositions and methods for treating centrally mediated nausea and vomiting | |
| JP2010533714A5 (https=) | ||
| JP6598841B2 (ja) | ツーピース硬カプセル用の耐酸性バンド溶液 | |
| EA013741B1 (ru) | Дисперсии наночастиц такролимуса с повышенными растворимостью в воде и биодоступностью, способы их приготовления и применения | |
| JP2013537903A (ja) | カラノライド、その誘導体及び類似体についての医薬組成物並びにそれを製造するための方法 | |
| WO2009068708A2 (es) | Composición farmacéutica de liberación sostenida de somatostatina o un análogo suyo | |
| JP2021152050A (ja) | フマル酸ジメチルを含む医薬ビーズ製剤 | |
| KR20190084998A (ko) | 제약 조성물 및 그의 용도 | |
| US20160193155A1 (en) | Pulsatile-release dosage form | |
| TWI834862B (zh) | 用於經口投遞滲透性不良蛋白質、肽及小分子之調配物 | |
| JP2016514706A5 (https=) | ||
| RU2015128028A (ru) | Длинноцепочечные липосбалансированные сложные эфиры тестостерона для пероральной доставки | |
| WO2022103833A1 (en) | Metal-organic framework mediated macromolecule delivery system | |
| TH1901003139A (th) | องค์ประกอบแคลเซียม แลคเตตและวิธีการใช้ | |
| JP2017518980A (ja) | タペンタドールを含む、改変防止即時放出カプセル製剤 | |
| JP7640453B2 (ja) | 医薬製剤およびその製造方法 | |
| TW201215412A (en) | Stable pharmaceutical composition | |
| JP2019517490A (ja) | がん療法のためのメトロノミック経口ゲムシタビン | |
| CN109662968A (zh) | 含A-失碳-5α雄甾烷化合物的升白制剂及其应用 | |
| AU2016280148A1 (en) | Extended release Capecitabine capsules | |
| US20060269596A1 (en) | Controlled release compositions comprising an acylanilide | |
| CN110290779A (zh) | 包含立即释放型卡培他滨和延长释放型卡培他滨的组合物 |